Oct 29 (Reuters) -
MITSUBISHI TANABE PHARMA CORP
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Full year to Full year ended
Sep 30, 2009 Sep 30, 2008 Mar 31, 2010 Mar 31, 2009
LATEST YEAR-AGO COMPANY YEAR-AGO
H1 RESULTS H1 RESULTS FORECAST RESULTS
Sales 198.24 206.34 408.00
(-3.9 pct) (-1.6%)
Operating 27.46 34.08 63.50
(-19.4 pct) (-11.4%)
Recurring 27.91 35.14 63.50
(-20.6 pct) (-12.5%)
Net 13.55 16.38 32.50
(-17.3 pct) (+22.5%)
EPS Y24.15 Y29.19 Y57.92
Annual div Y28.00 Y28.00
-Q2 div Y14.00 Y14.00
-Q4 div Y14.00 Y14.00
NOTE - Mitsubishi Tanabe Pharma Corp is a leading drug maker with strength in drugs
for circulatory system.
For latest earnings estimates made by Toyo Keizai, please
double click on 4508.TK1.